- Wiley partners with Amazon Web Services (AWS) to launch a generative AI agent for scientific literature search.
- The AI agent will debut at AWS Life Sciences Symposium in New York City on May 6.
- The collaboration aims to enhance research efficiency in the life sciences sector.
Wiley (WLY, Financial), a leading publisher in research and learning, has announced a strategic partnership with Amazon Web Services (AWS) to introduce a generative AI agent designed for scientific literature search. This novel AI agent will be presented at the upcoming 7th annual AWS Life Sciences Symposium in New York City on May 6.
The AI agent aims to revolutionize how researchers access and search scientific literature by offering comprehensive full-text searches of Wiley's expansive journal content. This approach surpasses the limitations of traditional abstract-only searches, allowing for detailed searches within sections such as methods and results.
As part of AWS’s open-source toolkit for healthcare and life sciences, the new AI agent can be customized for various applications, including biomarker discovery and clinical trial protocol creation. The integration includes freely accessible articles, such as those from Cancer Medicine, ensuring swift and reliable access to crucial scientific insights.
Josh Jarrett, SVP and GM of AI Growth at Wiley, emphasized the collaboration’s potential to empower researchers with complete literature searches, accelerating innovation in the life sciences field. Dan Sheeran, General Manager at AWS, highlighted the importance of integrating trusted information sources like Wiley’s content to enhance research discovery and development.
Wiley's commitment to responsible AI practices remains steadfast, focusing on core principles such as human oversight and transparency. This collaboration marks a significant step forward in Wiley’s mission to deliver innovative AI solutions while adhering to ethical standards.
